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Abstract
Purpose The aims of this study are to investigate the course of work functioning, health status, and work-related factors among
cancer patients during 18 months after return to work (RTW) and to examine the associations between these variables and work
functioning over time.
Methods Data were used from the 18-month longitudinal BWork Life after Cancer^ (WOLICA) cohort, among 384 cancer
patients who resumed work. Linear mixed models were performed to examine the different courses during 18-month follow-up.
Linear regression analyses with generalized estimating equations (GEE) were used to examine the associations and interactions.
Results Cancer patients reported an increase of work functioning and a decrease of fatigue and depressive symptoms in the first
12 months, followed by a stable course between 12 and 18 months. Cognitive symptoms were stable during the first 18 months.
Working hours increased and social support decreased during the first 6 months; both remained stable between 6 and 18 months.
Fatigue, depressive, and cognitive symptoms were negatively associated with work functioning over time; working hours and
supervisor social support were positively associated.
Conclusions Interventions to improve cancer patients’ work functioning over time might be promising if they are aimed at
reducing fatigue, depressive symptoms, cognitive symptoms, and encouraging supervisor social support.
Implications for Cancer Survivors It is important to monitor cancer patients not only in the period directly after RTW but up to
18 months after RTW, allowing for timely interventions when needed.
Keywords Cancer .Work functioning . Cognitive symptoms . Depressive symptoms .Workplace social support
Introduction
Survival rates of cancer patients are increasing, due to im-
provements in cancer diagnosis and treatment [1, 2]. More
than 60% of cancer patients return to work (RTW) within 1–
2 years after cancer diagnosis globally [3]. However, cancer
patients can experience difficulties when returning to work
due to cancer treatment or as a result of psychological
symptoms related to cancer diagnosis [4, 5]. Health-related
work functioning (hereafter referred to as work functioning)
measures the ability to meet the demands of work for a given
state of health [6–8]. Work functioning reflects the interplay
between work and health and might therefore be seen as a
highly valuable outcome [6–8].
Earlier, we have identified three distinct work functioning
trajectories in the year following RTWof cancer patients, and
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baseline cognitive symptoms, time between diagnosis and
RTW, and changed meaning of work were associated with
these trajectories [9]. To date, knowledge about the course of
work functioning in cancer patients during the first 18 months
after RTW is lacking. Moreover, little is known about how
health status and work-related factors (i.e., work demands
and social support) change over time and information about
their influence on work functioning over time in cancer pa-
tients is lacking. This knowledge is important for physicians
who treat cancer patients with paid work and for the develop-
ment of interventions to improve work functioning of cancer
patients.
Therefore, the aims of this study are (1) to investigate the
course of work functioning, health status, and work-related
factors in cancer patients during 18 months after RTW and
(2) to examine the associations between health status and
work-related factors with work functioning over time.
Material and methods
Study design and sample
The Work Life after Cancer (WOLICA) study is an 18-month
longitudinal cohort study among cancer patients. Cancer pa-
tients were included when they (1) were between 18 and
65 years old and (2) had resumed work for at least 12 h/week
during or following primary cancer treatment. Exclusion
criteria were (1) recurrent cancer, (2) treated with palliative
intent, (3) no paid employment for at least 1 year prior to
cancer diagnosis, and (4) not able to complete a questionnaire
in Dutch. Potential participants were identified and asked by
their Occupational Physician (OP) if they were interested to
participate in this study. If interested, OPs forwarded the can-
cer patients’ name and address to the research team. Cancer
patients who met the inclusion criteria received additional
information about the study, an informed consent, and the
baseline questionnaire. Cancer patients were included at base-
line within the first 3 months of working ≥ 12 h/week.
Participants received follow-up questionnaires, measuring
socio-demographics, health status, and work-related factors
every 3 months. WOLICA was reviewed and approved by
the Medical Ethical Committee of the University Medical
Center Groningen (M12.125242). A detailed description of
WOLICA has previously been reported [9].
Measures and procedure
Socio-demographics
Baseline age (in years), gender (male; female (ref)), education
(low, i.e., primary, junior secondary vocational, and junior
general secondary education; medium, i.e., senior secondary
vocational education and senior general secondary education;
high (ref), i.e., higher professional education, college, and
university), and marital status (single/divorced; married/
cohabitating (ref)) were used as covariates.
Work functioning
Work functioning was measured at baseline, 6, 12, and
18 months after RTW with the Work Role Functioning
Questionnaire (WRFQ 2.0; 27 items, α = 0.96) [8], a reliable
and validated questionnaire designed to measure difficulties in
meeting work demands perceived by workers with physical
health problems or emotional problems in the past 4 weeks. If
answers on ≥ 5 of the items were missing, the total score was
set to missing. The available amount and percentage of
person-measurement observations was 1197 (78%). Total
WRFQ-scores ranged from 0 to 100, with higher scores indi-
cating better work functioning.
Health status
Fatigue, depressive symptoms, and cognitive symptoms were
measured at baseline, 6, 12, and 18months after RTW. Fatigue
was measured with the Checklist for Individual Strength (CIS-
8) ‘fatigue severity’ subscale (8 items, α = 0.88) [10]. If an-
swers on > 2 of the items were missing, the total score was set
to missing. Total scores were calculated by summing the
scores on each item and ranged from 8 to 56, with higher
scores indicating more severe fatigue. A score of > 35 was
indicative of severe fatigue. Depressive symptoms were mea-
sured with the Patient Health Questionnaire-9 (PHQ-9; 9
items, α = 0.88) [11, 12]. If answers on > 3 of the items were
missing, the total score was set to missing. Total scores were
calculated by summing the scores on each item and total
scores ranged from 0 to 27, with higher scores indicating more
depressive symptoms. A score of ≥ 10 was indicative of clin-
ical depression. Work-specific cognitive symptoms were mea-
sured with the Cognitive Symptom Checklist-Work Dutch
Version (CSC-W DV; 19 items, α = 0.95) [13]. This reliable
and valid questionnaire [13] originated from the CSC-W21
[14], developed as a self-report measure of cognitive symp-
toms in the context of work. CSC-W scores are related to work
productivity [15] and work functioning [13]. If answers on > 3
of the items were missing, the total score was set to missing.
Total scores were calculated by summing the scores on each
item, divided by the number of items and then multiplying by
25. Total scores ranged from 0 to 100, with higher scores
indicating more work-specific cognitive symptoms.
Work-related factors
Perceived psychosocial work characteristics were measured at
baseline, 6, 12, and 18 months after RTW by the short version
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of the Copenhagen Psychosocial Questionnaire (COPSOQ)
[16] measuring quantitative demands (two items), work pace
(two items), influence at work (two items), meaning of work
(two items), social support from the supervisor (two items),
and social support from colleagues (two items). Total scores
were calculated by summing the items for each psychosocial
work characteristic and ranged from 0 to 8. Higher values
representing higher levels of the measured psychosocial work
characteristic. Working hours (per week) were assessed at
baseline, 6, 12, and 18 months after RTW.
Statistical analyses
First, the cancer patients’ socio-demographics, health sta-
tus, and work-related factors (i.e., mean, median, or per-
centage) were described. Second, the course of work func-
tioning, health status, and work-related factors during 18-
month follow-up was analyzed. Linear mixed models were
used to calculate estimated means with corresponding 95%
confidence intervals (CIs). Differences between baseline,
6, 12, and 18 months after RTW were tested with pairwise
comparisons. Bonferroni correction was used to correct for
multiple testing. Third, linear regression analyses with
generalized estimating equations (GEE) were performed
to examine the associations between health status and
work-related factors and the course of work functioning
during 18-month follow-up. With GEE, the relationships
between the variables of the model at different time-points
were analyzed simultaneously [17]. GEE takes the intra-
individual correlations between observations into account
[17]. An exchangeable structure was found most appropri-
ate after examining the correlation structure of the outcome
(WRFQ 2.0) and by comparing the quasi-likelihood under
the independence model criterion (QIC), with lower values
indicating better fit. Regression coefficients with corre-
sponding CIs for work functioning were presented, which
can be used to draw regression lines for cancer patients.
A total of six models were fitted: (1) an unconditional
growth model, which included work functioning and a cate-
gorical time variable; (2) age, gender, education, and marital
status were added to the first model, to control for socio-
demographics; (3) health status and (4) work-related factors
were added to the secondmodel, respectively; (5) health status
and work-related factors were included simultaneously; 6)
interaction terms for health status and time and for work-
related factors and time were added to the fifth model, one at
a time, whereby significant interaction terms (p < 0.05) were
retained in the subsequent and final model. Data were not
imputed; the available amount and percentage of person-
measurement observations for work functioning were report-
ed for models 1 and 6. Analyses were performed with SPSS
Statistics 23.
Results
Characteristics of cancer patients
A total of 384 cancer patients were included in the WOLICA
study. At baseline, n = 319 (83%) had complete WRFQ,
health status, and work-related factors data, n = 290 (76%) at
6 months, n = 262 (68%) at 12 months, and n = 258 (67%) at
18 months after RTW. Cancer patients had a mean age of 50.7
(SD = 8.6) years and 63% were female (Table 1). Breast can-
cer was most prevalent (46%), followed by gastrointestinal
cancer (15%), hematological cancer (11%), and urogenital
cancer (11%). Seventy-one percent of the cancer patients were
treated with systemic therapy exclusively or in combination
with radiotherapy and/or surgery. The time between diagnosis
and return to work was on average 7 months. Two-thirds of
the cancer patients had completed their treatment at baseline.
At baseline, cancer patients had aWRFQ score of 78.4 (CI:
76.6, 80.2), indicating that on average 22% of the time they
had difficulties meeting the demands of the job due to (phys-
ical or emotional) health problems (Table 2). Cancer patients
worked on average 19.0 (CI: 17.8, 20.1; interquartile range
Table 1 Baseline socio-demographics (n = 384)
Age in years, M (SD) 50.7 (8.6)





Marital status, n (%)
Married/cohabitating 305 (80)
Single/divorced/separated 78 (20)
Cancer site, n (%)
Breast cancer 178 (46)
Gastrointestinal cancer 58 (15)
Gynecological cancer 12 (3)
Hematological cancer 42 (11)
Skin cancer 16 (4)
Head and neck cancer 15 (4)
Urogenital cancer 41 (11)
Lung cancer 13 (3)
Other cancer 8 (2)
Type of treatment, n (%)
Surgery 59 (15)
Radiotherapy exclusively, or in combination with surgery 48 (13)
Systemic therapy exclusively, or in combination with
radiotherapy and/or surgery
271 (71)
Treatment completed (yes), n (%) 246 (64)
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(IQR): 12–24) hours per week at baseline. At that time, they
reported a mean fatigue score of 30.2 (CI: 29.0, 31.4; IQR:
22.0–37.8), a mean depressive symptoms score of 4.6 (CI:
4.3, 5.0; IQR: 2.0–7.0), and a mean cognitive symptom score
of 24.7 (CI: 23.0, 26.4; IQR: 13.2–24.0).
The course of work functioning, health status,
and work-related factors
In the first 12 months after RTW, cancer patients reported an
increase in work functioning (Δ0–12: 6.8) and a decrease in
fatigue (Δ0–12: − 2.3) and depressive symptoms (Δ0–12: −
0.8). Work functioning, fatigue, and depressive symptoms
remained stable between 12 and 18 months after RTW.
Cognitive symptoms were stable during the first 18 months
after RTW.
Cancer patients reported an increase in working hours in
the first 6 months after RTW (Δ0–6: 8.0). During that period,
they reported a decrease in social support from both the su-
pervisor (Δ0–6: − 0.4) and colleagues (Δ0–6: − 0.4). Working
hours and social support from supervisor and colleagues were
stable between 6 and 18 months after RTW. Additionally,
cancer patients reported a decreased meaning of work in the
first 12 months (Δ0–12: − 0.3), which was stable between 12
and 18 months after RTW. Quantitative demands, work pace,
and influence at work remained stable during the first
18 months after RTW.
The association among health status
and work-related factors and the course of work
functioning
The unconditional growth model showed an increase in work
functioning in the first 12 months after RTW, and work func-
tioning remained stable between 12 and 18 months (Table 3,
model 1; n = 1186 person-measurement observations, 77%).
Age, gender, education, and marital status did not change the
course of work functioning (model 2).
After adding health status (model 3), an increase in fa-
tigue (regression coefficient b: − 0.19; CI: − 0.27, − 0.11),
depressive symptoms (− 1.34; − 1.67, − 1.00), and cogni-
tive symptoms (− 0.41; − 0.49, − 0.34) was associated with
a decrease in work functioning. When adding work-related
factors (model 4), an increase in working hours (0.29; 0.17,
0.41), meaning of work (1.08; 0.36, 1.80), and supervisor
social support (1.00; 0.46, 1.55) was associated with an
increase in work functioning, while an increase in quanti-
tative demands (− 2.65; − 3.33, − 1.97) was associated with
a decrease in work functioning. Changes in work pace,
influence at work, and social support from colleagues did
not affect the course of work functioning over time. After
adding both health status and work-related factors (model
5), the associations remained similar, except for meaning
of work; this was no longer associated with the course of
work functioning over time.










Work functioning 78.4 (76.6, 80.2) 82.1 (80.2, 83.9) 3.6*** 85.2 (83.3, 87.1) 6.8*** 3.2** 85.2 (83.3, 87.2) 6.8*** 3.2** 0
Health status
Fatigue 30.2 (29.0, 31.4) 28.2 (27.0, 29.4) − 2.0** 27.9 (26.7, 29.1) − 2.3** − 0.3 27.8 (26.5, 29.0) − 2.4** − 0.4 − 0.1
Depressive
symptoms
4.6 (4.3, 5.0) 4.3 (3.9, 4.7) − 0.4 3.8 (3.4, 4.2) − 0.8*** − 0.5 4.1 (3.7, 4.5) − 0.6* − 0.2 0.3
Cognitive
symptoms




19.0 (17.8, 20.1) 26.9 (25.8, 28.1) 8.0*** 27.2 (26.0, 28.4) 8.2*** 0.3 26.2 (24.9, 27.4) 7.2*** − 0.8 − 1.0
Quantitative
demands
2.7 (2.5, 2.8) 2.7 (2.5, 2.8) 0.0 2.6 (2.4, 2.8) 0.1 − 0.1 2.6 (2.4, 2.8) − 0.1 − 0.1 0.0
Work pace 4.5 (4.3, 4.6) 4.6 (4.4, 4.8) 0.1 4.7 (4.5, 4.9) 0.2 0.1 4.6 (4.4, 4.8) 0.1 0.0 − 0.1
Influence at
work
4.5 (4.3, 4.7) 4.5 (4.3, 4.7) 0.0 4.4 (4.2, 4.6) 0.1 − 0.1 4.3 (4.1, 4.5) − 0.2 − 0.1 − 0.1
Meaning of
work
6.2 (6.0, 6.3) 5.9 (5.8, 6.1) − 0.2 5.8 (5.7, 6.0) − 0.3** − 0.1 5.8 (5.6, 5.9) − 0.4*** − 0.2 − 0.1
Social support
supervisor
5.3 (5.1, 5.5) 4.8 (4.6, 5.1) − 0.4*** 4.8 (4.6, 5.0) − 0.5*** 0.0 4.7 (4.4, 4.9) − 0.6*** − 0.2 − 0.2
Social support
colleagues
5.6 (5.4, 5.8) 5.2 (5.0, 5.4) − 0.4** 5.2 (5.0, 5.4) − 0.4** 0.0 5.2 (4.9, 5.4) − 0.5*** 0.0 − 0.1
*p < 0.05, **p < 0.01, ***p < 0.001. Bonferroni correction was used to correct for multiple testing
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When including interaction terms between health and
work-related factors with time (model 6, n = 1106 person-
measurement observations, 72%), the interaction terms be-
tween cognitive symptoms and time 3 (i.e., 12 months) and
depressive symptoms and time 3 were statistically significant.
When adding both interaction terms together to the subse-
quent and final model, both interaction terms remained not
significant.
Discussion
Cancer patients showed an increase in work functioning and a
decrease in fatigue and depressive symptoms during the first
12 months and stability between 12 and 18months after RTW.
Cognitive symptoms were stable during the first 18 months
after RTW. Working hours increased and social support from
supervisor and colleagues decreased in the first 6 months and
were stable between 6 and 18 months after RTW. Fatigue,
depressive symptoms, and cognitive symptoms were nega-
tively associated with work functioning over time, and work-
ing hours and supervisor social support were positively asso-
ciated with work functioning over time. The effects were the
same over time for all variables.
When returned to work, cancer patients experienced diffi-
culties in meeting their job demands due to (physical or emo-
tional) health problems for 22% of their time at work. During
the first 12 months after RTW, the amount of time experienc-
ing difficulties decreased to 15% and remained stable between
12 and 18 months. Due to this reduction in experienced diffi-
culties, cancer patients’ level of work functioning 1 year after
RTW is similar to the level of work functioning in the general
working population [8].
Fatigue and depressive symptoms were decreasing during
the first 12 months after RTWand were stable between 12 and
18 months. Even though cancer patients were already below
clinical cut-offs for fatigue and depressive symptoms [10, 12],
their level of fatigue and depressive symptoms decreased after
RTW. Work-specific cognitive symptoms were stable during
the first 18 months after RTW. Previous research in cancer
patients showed that cognitive impairments are typically sub-
tle, with symptoms across various domains of cognition, i.e.,
working memory, executive function, and processing speed
[18–20]. While acute cognitive changes during chemotherapy
are common [19, 20], long-term post-treatment cognitive
changes only persist in a subgroup (17–34%) of cancer pa-
tients [21]. To gain more knowledge about subgroups of can-
cer patients with different courses of work-specific cognitive
symptoms and their determinants, more research is needed.
The current longitudinal study identified negative associa-
tions between fatigue, depressive symptoms, and cognitive
symptoms with work functioning over time. A recent system-
atic review on physical and psychosocial problems associated
with difficulties at work in cancer patients beyond RTW
showed similar associations, although mainly based on
cross-sectional research [22]. The negative associations over
time can be interpreted in two ways (i.e., both as a between
and a within person effect) [17]. First, cancer patients with
fewer health problems (i.e., lower fatigue, depressive symp-
toms scores, and/or cognitive symptoms) had higher work
functioning scores compared to cancer patients with more
health problems. Second, a decline in health problems within
one cancer patient (i.e., an improvement in health) was asso-
ciated with an increase in work functioning over time, indicat-
ing that an improvement in health can be beneficial for work
functioning.
Cancer patients reported an increase in working hours dur-
ing the first 6 months after RTW, but their working hours were
stable between 6 and 18 months after RTW even though they
did not reach their contracted working hours (data not shown).
The positive association found in this study might be ex-
plained by an improvement in health, which allows for better
scores on work functioning and for a possibility to work more
hours per week. Further research is needed to elaborate this in
more detail.
In line with previous research [23, 24], workplace social
support decreased over time, especially in the first 6 months
after RTW. When examining the association between social
support and work functioning over time, higher supervisor
support was related to better work functioning over time.
Therefore, the observed decrease of workplace social support
might negatively affect cancer patients’work functioning over
time. Continuous supervisor social support might be impor-
tant when guiding and accommodating cancer patients at
work. The fact that social support was not associated with
work functioning in the general working population [25] sug-
gests that workplace social support is more important for work
functioning in vulnerable populations, as has previously been
shown [26–28].
Several strengths and limitations have to be addressed. A
strength of this study is the longitudinal design with repeated
measurements of work functioning, health status, and work-
related factors at baseline, 6, 12, and 18 months after RTW.
Data were available from all four measurement points for the
majority of participants. Another strength is the heterogeneous
sample of cancer patients with different cancer diagnoses and
treatments. In this study, work functioning scores were posi-
tively skewed to the right, both at baseline and at follow-up.
Therefore, we used GEE analyses instead of mixed models,
which allowed for weaker distributional assumptions [29].
The lack of information about cancer patients who were not
asked to participate or were asked but not willing to participate
is a study limitation. Consequently, it is not possible to state
that the study sample is representative of all cancer patients
who resumed work after cancer diagnosis and treatment.
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































healthy workers or workers with other chronic conditions. In
future studies, adding a comparison group could provide ad-
ditional valuable information to interpret our findings. It is
also important to note that both the independent and depen-
dent variables were measured with self-reported measures,
which might have resulted in an overestimation of the associ-
ations due to shared method variance or shared response
biases [30].
In the future, interventions to improve work functioning
might be successful when reducing fatigue, depressive symp-
toms, and cognitive symptoms of cancer patients, because a
reduction of these symptoms is related to an increase in work
functioning over time. For interventions to reduce cognitive
symptoms, it is important to take the specific work situation
into account, since cancer patients indicate these cognitive
symptoms in relation to work. Furthermore, we have to inform
employers and (occupational) physicians about the impor-
tance of continuing supervisor social support on a regular
basis. To improve work functioning, it is important to monitor
cancer patients not only in the period directly after RTW but
up to 18 months after RTW, allowing for timely interventions
when needed.
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